Abstract:Background Osteosarcoma (OS) is the most prevalent primary bone sarcoma in the global child and young adult population, and the current mainstream treatment regimens are not very effective. The unique efficacy of traditional Chinese medicine (TCM) for cancers has recently received increasing attention. Oldenlandia diffusa (OD) is commonly used as adjuvant therapy for various cancers in Chinese herb medicine (CHM) with its unique pharmacological activities, but its therapeutic effect as well as the underlying mechanism against OS has yet to be systematically investigated. Objective This study aims to find the underlying active mechanism of OD against OS. Methods The candidate ingredients as well as drug targets of OD were obtained from the Traditional Chinese Medicine System Pharmacology (TCMSP) database, respectively. Meanwhile, the OS disease-related targets were acquired from GeneCards and MalaCards online databases. Then, by using Venny 2.1, the common key targets were imported into the STRING database to acquire their interaction relationship, and imported this PPI network file (.csv) into Cytoscape 3.6.0 software and merged to obtain PPI network intersections. Meanwhile, the MCODE plugin of Cytoscape was also used to further trim the core therapeutic targets. GO and KEGG enrichment and molecular docking analyses were performed to predict the underlying mechanism of OD against OS. Furthermore, in silico analysis results were validated by a series of cellular functional and molecular biological assays. Results A total of 131 putative targets were identified to be involved in the anti-OS activity of OD. The PPI network, GO as well as KEGG analyses revealed that the 18 core targets were closely related to cell proliferation, apoptosis. Importantly, the subsequent in vitro assays verified that the suppressive effect of OD on OS cell growth indeed resulted from disrupted apoptosis and cell proliferation via Akt and ERK signaling pathways. Furthermore, our results showed that quercetin, beta-sitosterol and 2-methoxy-3-methyl-9,10-anthraquinone were the key ingredients, while PTGS2, CASP3 and JUN were the key targets in delivering the pharmacological activities of OD against OS, thus providing an insight into the anti-OS action of OD from a holistic perspective. Conclusion In summary, our results indicate that OD has good prospects in the treatment of OS.

Exploring the underlying mechanism of oleanolic acid treating glioma by transcriptome and molecular docking

Transcriptome Study of Oleanolic Acid in the Inhibition of Breast Tumor Growth Based on High-Throughput Sequencing.

Silico analysis of the target and possible mechanism of lomustine in the treatment of primary glioblastoma

Exploring the Antiglioma Mechanisms of Luteolin Based on Network Pharmacology and Experimental Verification

Anticancer effects of OSW-1 on glioma cells via regulation of the PI3K/AKT signal pathway: A network pharmacology approach and experimental validation in vitro and in vivo

Oligomer-Aβ42 Suppress Glioma Progression Via Potentiating Phagocytosis of Microglia

A Network Pharmacology Guided Mechanism of Action Study on <i>Oldenlandia diffusa</i> Against Osteosarcoma

Inhibition of mTOR signaling by oleanolic acid contributes to its anti-tumor activity in osteosarcoma cells.

Oleanolic acid induces mitochondrial-dependent apoptosis and G0/G1 phase arrest in gallbladder cancer cells

Elucidation of the mechanism of action of ailanthone in the treatment of colorectal cancer: integration of network pharmacology, bioinformatics analysis and experimental validation

Identification of Aloperine As an Anti-Apoptotic Bcl2 Protein Inhibitor in Glioma Cells

Molecular Mechanism of GANT61 Combined with Doxorubicin in the Treatment of Gliomas Based on Network Pharmacology

Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation

Network Pharmacology-Based Strategy to Investigate the Effect and Mechanism of Α-Solanine Against Glioma

Effect of luteolin on glioblastoma's immune microenvironment and tumor growth suppression

Oleanolic acid induces osteosarcoma cell apoptosis by inhibition of Notch signaling.

Biological Evaluation of Lysionotin: a Novel Inhibitor of 5-Lipoxygenase for Anti-glioma

Network Pharmacology-Based Analysis on the Action Mechanism of Oleanolic Acid to Alleviate Osteoporosis

Multiomics integration reveals the effect of Orexin A on glioblastoma

Revealing the Role of Honokiol in Human Glioma Cells by RNA-seq Analysis

Baohuoside I via mTOR Apoptotic Signaling to Inhibit Glioma Cell Growth